drugset / Trial / NCT04985682
A Study of ADVATE in People With Hemophilia A in India
Phase 4
Completed
50 enrolled
Baxalta now part of Shire
Takeda Development Center Americas, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
The main aim of this study is to learn more about side effects of Advate when given as standard treatment to people with hemophilia A who have already been treated. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study. Participants will need to visit the study doctor 5 times in total during the study. During these visits, study data will be collected by the study doctor.
Timeline
- Start
- 2022-01-14
- Primary completion
- 2023-02-10
- Completion
- 2023-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADVATE | Protein / enzyme biologic | — | — |